Novartis AG (NVS)
97.73
+0.46
(+0.47%)
USD |
NYSE |
May 06, 16:00
97.74
0.00 (0.00%)
Pre-Market: 20:00
Novartis Shares Outstanding: 2.040B for March 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 31, 2024 | 2.040B |
December 31, 2023 | 2.044B |
September 30, 2023 | 2.055B |
June 30, 2023 | 2.068B |
March 31, 2023 | 2.097B |
December 31, 2022 | 2.120B |
September 30, 2022 | 2.151B |
June 30, 2022 | 2.183B |
March 31, 2022 | 2.213B |
December 31, 2021 | 2.235B |
September 30, 2021 | 2.237B |
June 30, 2021 | 2.237B |
March 31, 2021 | 2.245B |
December 31, 2020 | 2.257B |
September 30, 2020 | 2.274B |
June 30, 2020 | 2.289B |
March 31, 2020 | 2.289B |
December 31, 2019 | 2.265B |
September 30, 2019 | 2.265B |
June 30, 2019 | 2.292B |
May 14, 2019 | 2.294B |
March 31, 2019 | 2.323B |
December 31, 2018 | 2.311B |
September 30, 2018 | 2.31B |
June 30, 2018 | 2.322B |
Date | Value |
---|---|
May 16, 2018 | 2.318B |
March 31, 2018 | 2.331B |
December 31, 2017 | 2.317B |
June 30, 2017 | 2.343B |
March 31, 2017 | 2.366B |
December 31, 2016 | 2.374B |
September 30, 2016 | 2.376B |
June 30, 2016 | 2.381B |
March 31, 2016 | 2.381B |
December 31, 2015 | 2.374B |
September 30, 2015 | 2.396B |
June 30, 2015 | 2.415B |
March 31, 2015 | 2.420B |
December 31, 2014 | 2.399B |
September 30, 2014 | 2.419B |
June 30, 2014 | 2.426B |
March 31, 2014 | 2.447B |
December 31, 2013 | 2.426B |
September 30, 2013 | 2.435B |
June 30, 2013 | 2.447B |
March 31, 2013 | 2.457B |
December 31, 2012 | 2.421B |
September 30, 2012 | 2.419B |
June 30, 2012 | 2.418B |
March 31, 2012 | 2.422B |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
2.040B
Minimum
Mar 31 2024
2.294B
Maximum
May 14 2019
2.198B
Average
2.237B
Median
Jun 30 2021
Shares Outstanding Benchmarks
Roche Holding AG | 6.378B |
Sandoz Group AG | 431.00M |
Amgen Inc | 536.43M |
Incyte Corp | 224.54M |
MorphoSys AG | 150.87M |